medigraphic.com
ISSN 2078-7170 (Electronic)

2022, Number 2

<< Back Next >>

CorSalud 2022; 14 (2)

Coronary risk factors and their relationship with complications of atrial fibrillation

Seixas DH, Leal BE, Arjona RIA, Massip NJ, Fernández MH, Anido BM, Reyes FL, López FA, Guadalupe SA, Peña CIM, Machín ML, Ocaña AL

Language: Spanish
References: 33
Page: 154-163
PDF size: 281.85 Kb.


ABSTRACT

Introduction: Atrial fibrillation is one of the most important causes of stroke, heart failure, sudden death and cardiovascular morbidity worldwide.
Objective: To describe the relationship of coronary risk factors with complications of patients with atrial fibrillation.
Method: Descriptive, cross-sectional study; including 102 patients with a diagnosis of atrial fibrillation, admitted to the department of Cardiology of the Hospital Uni-versitario Clínico Quirúrgico General Calixto García, from January 2019 to July 2020.
Results: Males prevailed (65.7%). A total of 77.5% of patients were hypertensive, 41.2% were overweight and 38.2% were obese. A 21.6% referred personal history of diabetes mellitus and 64.7% had increased fasting blood glucose. Some complica-tion was observed in 58 patients, with heart failure (42.2%) and cerebral embolism (7.8%) standing out. An association between the increased risk of complications and the presence of coronary risk factors was observed. In patients with high blood pressure, the risk of complications was 7.66 times higher.
Conclusions: More than half of the patients studied presented some complication related to arrhythmia, the most frequent being heart failure. Coronary risk factors were present in most of these patients with a predominance of high blood pres-sure, obesity and diabetes mellitus. The presence of coronary risk factors was associated with an increased risk of complications in patients with atrial fibrilla-tion.


REFERENCES

  1. Collazo Rodríguez MP, Rodríguez Leyva D, Pérez Martín O, Cruz Cardentey M, Mengana Betancourt A. La epidemiología de la fibrilación auricular después de 390 años. CCM [Internet]. 2019 [citado 22 Abr 2021];23(2):1324-37. Disponible en:http://revcocmed. sld. cu/index. php/cocmed/article/view/2566/1416

  2. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guide-lines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Sur-gery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the Euro-pean Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373-498. [DOI]

  3. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epi-demiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-47. [DOI]

  4. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019; 139(10):e56-e528. [DOI]

  5. Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the Euro-pean Union, from 2000 to 2060. Eur Heart J. 2013; 34(35):2746-51. [DOI]

  6. Zamorano JL. La fibrilación auricular en las guías de práctica clínica. Rev Esp Cardiol. 2016;16(A): 52-4. [DOI]

  7. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, et al. 50 year trends in atrial fi-brillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A co-hort study. Lancet. 2015;386(9989):154-62. [DOI]

  8. Moreno LE, Hernández IT, Moreno R, García G, Suárez R. Fibrilación auricular en pacientes con ictus isquémico en Hospital Universitario Co-mandante Faustino Pérez. 2017. Rev Méd Elec-trón [Internet]. 2018 [citado 23 Abr 2021];40(2): 360-70. Disponible en:http://www. revmedicaelectronica. sld. cu/index. php/rme/article/view/2636/pdf_399

  9. Castro Clavijo JA, Quintero S, Valderrama F, Diaz-tagle JJ, Ortega J. Prevalencia de la fibrilación au-ricular en pacientes hospitalizados por Medici- na Interna. Rev Colomb Cardiol. 2020;27(6):560-6. [DOI]

  10. Ministerio de Salud Pública. Anuario Estadístico de Salud 2018. La Habana: Dirección de Registros Médicos y Estadísticas de Salud; 2019.

  11. 11.Wilkinson C, Todd O, Clegg A, Gale CP, Hall M. Management of atrial fibrillation for old er people with frailty: a systematic review and meta-anal-ysis. Age Ageing. 2019;48(2):196-203. [DOI]

  12. Lago Santiesteban D, Lago Santiesteban Y, Bárza-ga Morell S, Iglesias Pérez O, Vega Torres R. Fac-tores de riesgo de enfermedad cerebrovascular isquémica en pacientes con fibrilación auricular. MULTIMED [Internet]. 2016 [citado 23 Abr 2021]; 20(3):518-42. Disponible en:http://www. revmultimed. sld. cu/index. php/mtm/article/view/198/227

  13. Rodríguez Jiménez AE, Cruz Inerarity H, Toledo Rodríguez E, Quintana Cañizares G. Fibrilación auricular de novo ¿incrementa la mortalidad intrahospitalaria en el infarto miocárdico con ele-vación del ST? Rev Finlay [Internet]. 2017 [citado 24 Abr 2021];7(4):240-9. Disponible en:http://revfinlay. sld. cu/index. php/finlay/article/view/547/1618

  14. Fernández González EM, Figueroa Oliva DA. Ta-baquismo y su relación con las enfermedades car-diovasculares. Rev Habanera Cienc Méd [Inter-net]. 2018 [citado 24 Abr 2021];17(2):225-35. Dis-ponible en:http://www. revhabanera. sld. cu/index. php/rhab/article/view/2044/2069

  15. Pérez Caballero MD, León Álvarez JL, Dueñas Herrera A, Alfonzo Guerra JP, Navarro Despaigne DA, de la Noval García R, et al. Guía cubana de diagnóstico, evaluación y tratamiento de la hiper-tensión arterial. Rev Cuban Med [Internet]. 2017 [citado 18 Sep 2019];56(4):242-321. Disponible en: http://scielo. sld. cu/pdf/med/v56n4/med01417. pdf

  16. Verdecchia P, Angeli F, Reboldi G. Hypertension and atrial fibrillation: Doubts and certainties from basic and clinical studies. Circ Res. 2018;122(2): 352-68. [DOI]

  17. Magnani JW, Norby FL, Agarwal SK, Soliman EZ, Chen LY, Loehr LR, et al. Racial Differences in Atrial Fibrillation-Related Cardiovascular Disease and Mortality: The Atherosclerosis Risk in Com-munities (ARIC) Study. JAMA Cardiol. 2016;1(4): 433-41. [DOI]

  18. Tikhonoff V, Kuznetsova T, Thijs L, Cauwenberghs N, Stolarz-Skrzypek K, Seidlerová J, et al. Ambula-tory blood pressure and long-term risk for atrial fibrillation. Heart. 2018;104(15):1263-70. [DOI]

  19. Goire Guevara G, Cuza Díaz LA, Fournier Calzado G, González Marrero J, Montero Vega V. Factores de riesgo en complicaciones tromboembólicas cerebrales de pacientes con fibrilación auricular permanente no valvular. Rev Inf Cient [Internet]. 2019 [citado 25 Abr 2021];98(1):77-87. Disponible en: http://www. revinfcientifica. sld. cu/index. php/ric/article/view/2207/3966

  20. Guerra García D, Valladares Carvajal F, Bernal Valladares EJ, Díaz Quiñones JA. Factores de riesgo asociados a ictus cardioembólico en pa-cientes con fibrilación auricular no valvular. Rev Finlay [Internet]. 2018 [citado 25 Abr 2021];8(1):9-17. Disponible en:http://revfinlay. sld. cu/index. php/finlay/article/view/577/1640

  21. Pouwels S, Topal B, Knook MT, Celik A, Sundbom M, Ribeiro R, et al. Interaction of obesity and atri-al fibrillation: an overview of pathophysiology and clinical management. Expert Rev Cardiovasc Ther. 2019;17(3):209-23. [DOI]

  22. Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX, et al. Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). J Am Coll Cardiol. 2015;65(20):2159-69. [DOI]

  23. Proietti M, Guiducci E, Cheli P, Lip GY. Is There an Obesity Paradox for Outcomes in Atrial Fibril-lation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Tri-als. Stroke. 2017;48(4):857-66. [DOI]

  24. Kachur S, Lavie CJ, de Schutter A, Milani RV, Ventura HO. Obesity and cardiovascular diseas-es. Minerva Med. 2017;108(3):212-28. [DOI]

  25. Cinza Sanjurjo S, Prieto Díaz MA, Llisterri Caro JL, Barquilla García A, Rodríguez Padial L, Vidal Pé-rez R, et al. Prevalencia de obesidad y comorbili-dad cardiovascular asociada en los pacientes in-cluidos en el estudio IBERICAN (Identificación de la poBlación Española de RIesgo CArdiovascular y reNal). Semergen. 2019;45(5):311-22. [DOI]

  26. Cañón Montañez W, Santos A, Nunes LA, Pires JC, Freire C, Ribeiro AL, et al. La obesidad central es el componente clave en la asociación del sín-drome metabólico con el deterioro del strain lon-gitudinal global del ventrículo izquierdo. Rev Esp Cardio. 2018;71(7):524-30. [DOI]

  27. Ávila Cortez IR. Factores de riesgo prevalentes para fibrilación auricular en pacientes adultos [Tesis]. Universidad Nacional de Trujillo [Inter-net]; 2020 [citado 28 Abr 2021]. Disponible en: https://dspace. unitru. edu. pe/handle/UNITRU/16171

  28. Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabe-tes Mellitus: Atherosclerotic Cardiovascular Dis-ease and Heart Failure in Type 2 Diabetes Melli-tus - Mechanisms, Management, and Clinical Con-siderations. Circulation. 2016;133(24):2459-502. [DOI]

  29. Qi W, Zhang N, Korantzopoulos P, Letsas KP, Cheng M, Di F, et al. Serum glycated hemoglobin level as a predictor of atrial fibrillation: A system-atic review with meta-analysis and meta-regres-sion. PLoS One [Internet]. 2017 [citado 28 Abr 2021];12(3):e0170955. Disponible en:https://doi. org/10. 1371/journal. pone. 0170955

  30. O'Neal WT, Nazarian S, Alonso A, Heckbert SR, Vaccarino V, Soliman EZ. Sex hormones and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA). Endocrine. 2017;58(1): 91-6. [DOI]

  31. Azcuy Ruiz M, Sandrino Sánchez M, Lima Fuen-tes L, Valle González D, González Landeiro F. Fac-tores de riesgo hemorrágico según HAS-BLED en pacientes con fibrilación auricular no valvular. Rev Cienc Méd Pinar Río [Internet]. 2020 [citado 28 Abr 2021];24(4):e4371. Disponible en:http://www. revcmpinar. sld. cu/index. php/publicaciones/article/view/4371/pdf

  32. Vitón Castillo AA, Rego Ávila H. Consideracionesfisiopatológicas y diagnósticas sobre la fibrilación auricular. Rev Cuban Med Int Emerg [Internet]. 2020 [citado 28 Abr 2021];19(2):e699. Disponible en: http://www. revmie. sld. cu/index. php/mie/article/view/699

  33. Miller JD, Aronis KN, Chrispin J, Patil KD, Marine JE, Martin SS, et al. Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fi-brillation. J Am Coll Cardiol. 2015;66(25):2899-906. [DOI]




2020     |     www.medigraphic.com